DCPH

Deciphera Pharmaceuticals, Inc.

12.08 USD
-0.03 (-0.25%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Deciphera Pharmaceuticals, Inc. stock is up 1.26% since 30 days ago. The next earnings date is Feb 6, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 71.43% of the previous 6 November’s closed higher than October. In the last 2 Unusual Options Trades, there were 2 CALLs. 80% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
10 Oct 18:19 19 Jan, 2024 12.50 CALL 490 107
20 Oct 14:00 19 Jan, 2024 12.50 CALL 395 609

About Deciphera Pharmaceuticals, Inc.

Deciphera Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts. Its lead drug candidate is QINLOCK used for the treatment of gastrointestinal stromal tumors (GIST)

  • JP Morgan
    Mon Nov 20, 08:16
    hold
    confirm
  • Stifel
    Tue Oct 31, 13:59
    buy
    confirm
  • HC Wainwright & Co.
    Tue Oct 31, 07:34
    buy
    confirm
  • JonesTrading
    Tue Oct 31, 05:50
    buy
    upgrade
  • Piper Sandler
    Mon Oct 30, 12:55
    buy
    upgrade